OverviewChartNewsTraderScreen

Context Therapeutics/  US21077P1084  /

IEX
2024-07-26  9:59:46 PM Chg. +0.07 Volume Bid- Ask- High Low
2.51USD +2.87% 1,367
Turnover: 3,420.99		 -Bid Size: - -Ask Size: - 2.53 2.48
GlobeNewswire 05-08 Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire 05-02 Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM...
GlobeNewswire 05-02 Context Therapeutics Announces $100 Million Private Placement
GlobeNewswire 04-01 Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
GlobeNewswire 03-21 Context Therapeutics Reports Full Year 2023 Operating and Financial Results
GlobeNewswire 2023-11-09 Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
GlobeNewswire 2023-10-31 Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of i...
GlobeNewswire 2023-09-27 Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunothera...
Newsfile Corp 2022-10-20 Context Therapeutics to Participate in the ThinkEquity Conference
GlobeNewswire 2022-03-23 Context Therapeutics® Reports Full Year 2021 Operating and Financial Results
GlobeNewswire 2022-03-09 Proactive news headlines including Bitcoin, Lifeist Wellness, Imperial Helium, Fabled Copper, Contex...
GlobeNewswire 2022-03-09 Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Associa...
GlobeNewswire 2022-02-24 Proactive news headlines including Thunderbird Entertainment, NorthWest Copper, East Side Games, Ame...
GlobeNewswire 2022-02-23 Proactive news headlines including TRACON Pharmaceuticals, Gratomic, Benchmark Metals, Potent Ventur...
GlobeNewswire 2022-02-22 Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum
GlobeNewswire 2022-01-05 Context Therapeutics® Strengthens Research & Development Team
GlobeNewswire 2022-01-04 Context Therapeutics® to Participate in Two January 2022 Investor Conferences
GlobeNewswire 2021-12-10 Proactive news headlines including Tesla, Great Atlantic Resources, American Battery Technology Comp...
GlobeNewswire 2021-12-10 Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio...
GlobeNewswire 2021-12-07 Proactive news headlines including BuzzFeed, Steppe Gold, Esports Entertainment Group, Sanatana Res...
GlobeNewswire 2021-12-06 Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement
GlobeNewswire 2021-12-03 Proactive news headlines including Elon Musk, Vuzix, Context Therapeutics and American Manganese
GlobeNewswire 2021-12-02 Context Therapeutics® Reports Third Quarter 2021 Operating and Financial Results
GlobeNewswire 2021-12-02 Context Therapeutics Inc. Announces $31.25 Million Private Placement
GlobeNewswire 2021-11-19 Context Therapeutics® to Present Clinical Data on ONA-XR in Breast Cancer at 2021 San Antonio Breast...